Our team will be attending the 17th International Congress on Neuromuscular Diseases (ICNMD 2022) in Brussels this week from 5-9 July.
Our CEO Thomas Holm Pedersen - along with Senior Scientist Martin Brandhøj Skov - will be on the ground in Belgium meeting with peers and colleagues from the #neuromusculardisease community.
Our team will be attending the 17th ICNMD 2022 in Brussels
Previous
Previous
An active future made possible by the power of science
Next
Next